🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07753291
Recruiting Not applicable

The Effects of the Yi Jin Jing on the Muscles and Bones of Adults

NCT07753291 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Hospital of Traditional Chinese Medicine
Phase
Not applicable
Started
2026-09-01
Last updated
2026-09-01

Condition(s) studied

Musculoskeletal HealthHealthy Adult Volunteers

Investigational drug(s) / intervention(s)

Yijinjing

Yijinjing: Yijinjing

Study summary

Observation of the effects of Yi Jin Jing on the muscles and bones of adults

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18-90 years inclusive; * Generally healthy, no acute or chronic diseases affecting major organ functions; * No cognitive impairment, able to understand and comply with study procedures; * Willing and able to provide written informed consent; * No pregnancy or lactation (for females); * No recent (within 3 months) major surgery, hospitalization, or significant weight change (\>5% body weight). Exclusion Criteria: * Presence of acute or unstable chronic diseases (e.g., uncontrolled hypertension, diabetes, heart failure, or malignancy); * Severe cognitive impairment, psychiatric disorders, or inability to follow study instructions; * Recent (≤3 months) major surgery, trauma, or hospitalization; * Pregnancy, lactation, or childbearing potential without reliable contraception; * Body mass index (BMI) \<16 or \>40 kg/m²; * Current use of medications affecting muscle or nutritional metabolism (e.g., corticosteroids, anabolic steroids); * Participation in another interventional trial within 30 days.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
No. 23, Ganju Road, Dongcheng District, Beijing Beijing China Recruiting

More Beijing Hospital of Traditional Chinese Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07753291 on ClinicalTrials.gov ↗ ← All trials in China